Jared M Weiss MD

Oncology•Chapel Hill, NC

Head & Neck Cancer, Hematologic Oncology, Thoracic Cancer

Physician

Join to View Full Profile

101 Manning DrChapel Hill, NC 27514
Phone+1 984-974-0000
Fax+1 984-974-2607

Education & Training

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2007 - 2010
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2004 - 2007
Yale School of MedicineClass of 2004

Certifications & Licensure

NC State Medical License 2010 - 2025
PA State Medical License 2007 - 2010
MA State Medical License 2006 - 2009
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2012 Feb 01
Completed
Phase 2
Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR) Start of enrollment: 2012 Dec 11
Completed
Phase 2
Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
ACTIVE_NOT_RECRUITING
PHASE2
Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer Start of enrollment: 2012 Jul 01
Completed
Single Arm on the Tolerability of Weekly Nab-paclitaxel Start of enrollment: 2013 Jun 25
Completed
Phase 2
Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy Start of enrollment: 2012 Oct 01
Completed
Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN Start of enrollment: 2014 Jun 16
Completed
Phase 2
Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly Start of enrollment: 2014 Jun 09
Completed
Phase 4
Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC Start of enrollment: 2015 Jan 01
Terminated
Phase 2
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) Start of enrollment: 2015 Jun 26
Completed
Phase 1, Phase 2
Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy Start of enrollment: 2015 Oct 05
Terminated
Phase 1, Phase 2
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC Start of enrollment: 2024 Apr 16
RECRUITING
PHASE1, PHASE2
Roles: Principal Investigator, Contact
Study of Trilaciclib and Lurbinectidin Start of enrollment: 2022 Oct 12
RECRUITING
PHASE2
Roles: Principal Investigator, Contact
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors Start of enrollment: 2023 Jun 26
RECRUITING
Roles: Contact
A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors Start of enrollment: 2024 May 06
RECRUITING
PHASE1
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis.
Margaret Stalker, Connor B Grady, Alex Watts, Wei-Ting Hwang, Krishna Chandrasekhara
JTO Clinical and Research Reports. 2025-01-01
Phase I study of allogeneic monocyte-derived inflammatory dendritic cells in combination with pembrolizumab.
Jared Weiss, Douglas Laux, David Bajor, Albert C Lockhart, John Hamm
Future Science OA. 2024-12-01
1 citations
Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer.
Connor B Grady, Wei-Ting Hwang, Joshua E Reuss, Wade Iams, Amanda Cass
Pharmacoepidemiology and Drug Safety. 2024-12-01

Lectures

Preliminary toxicity data from the combination of pembrolizumab and definitive-dose radiotherapy for locally advanced head and neck cancer with contraindication to cis...
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Postoperative Chemoradiation: Which Patients, Which Agents?
2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018

Press Mentions

Warning on Use of Sotorasib After ICI in Lung CancerJune 1st, 2023
Lung Cancer Symptoms in Non-Smokers Misdiagnosed with COVIDFebruary 14th, 2023
Woman, 39, Had Cough Diagnosed as COVID-19 Pneumonia. It Was Lung CancerMay 18th, 2022
Join now to see all

Jared M Weiss MD

Dr. Weiss is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.